10
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Crohn's Disease

A Clinical Study Based on 186 Patients

, &
Pages 97-108 | Received 10 Aug 1970, Accepted 07 Oct 1970, Published online: 25 Feb 2010
 

Abstract

In a series of 186 patients with Crohn's disease, although stringent indications for operation were required, about 90% of the patients underwent surgery during the period of observation. The recurrence rate after resection was 39%. Bypass operation gave poor results. Relatively ‘radical’ resection seems to give a better result than less ‘radical’ operations. This held for both the number and especially for degree of severity of recurrences. Recurrences with reoperation were followed by a further recurrence rate of 43%. The operative mortality was 3.6%. The total mortality from Crohn's disease or its complications during the period of observation was 5.4% for the whole series. With the relatively active attitude to surgery as regards treatment of recurrent lesions, 88% of all the patients in the initial series are now doing full-time work, and 12% have severe symptoms or are dead from Crohn's disease or its complication. Of the 88%, 11% have moderate, and 77%, no or only very slight symptoms. The majority of patients not operated on or patients with recurrent lesions after operation have been treated with corticosteroids and Salazopyrin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.